Literature DB >> 18823795

Comparative study of four different spherical embolic particles in an animal model: a morphologic and histologic evaluation.

José I Bilbao1, Esther de Luis, José A García de Jalón, Alba de Martino, María D Lozano, Antonio Martínez de la Cuesta, Bruno Sangro.   

Abstract

PURPOSE: To perform a study in a porcine model comparing four different spherical embolic particles in terms of postembolization patency, deformation, and potential for recanalization, with a focus on a relatively new agent--HepaSphere.
MATERIALS AND METHODS: Partial embolization of both kidneys was performed in 18 pigs. Nine animals were sacrificed at 48 hours and nine at 4 weeks. In the same animal, the right kidney was embolized with HepaSphere particles ("dry" size, 50-100 microm; presumed final size, 200-300 microm), and the left kidney was alternatively embolized with EmboSphere (100-300 microm), Contour (150-350 microm), or Bead Block (150-350 microm) particles. The authors analyzed the size, deformation, and number of particles in each vessel, their morphologic characteristics, and recanalization.
RESULTS: Particle sizes and deformation (1,096 particles) were as follows: HepaSphere, 225.3 microm +/- 67 and 26% +/- 19.7, respectively; EmboSphere, 132.9 microm +/- 36 and 18.1% +/- 14.2; Bead Block, 108.1 microm +/- 38 and 16.5% +/- 13.9; and Contour, 240.8 microm +/- 135 and 55.5% +/- 33. HepaSphere and Bead Block particles were distally located, and EmboSphere and Contour particles were located more proximally. EmboSphere and Bead Block particles were round, HepaSphere particles were round and/or ovoid, and Contour particles had an amorphous aspect. EmboSphere particles had a higher tendency to aggregate. No recanalization was seen with HepaSphere particles, and variable recanalization was observed with the others.
CONCLUSIONS: Despite similar initial morphologic characteristics, the performance of the agents tested in this study differed in terms of final size, shape, deformation, and luminal recanalization. These differences have potential clinical relevance, and the knowledge of the differing embolic performance may be helpful in choosing agents for specific therapeutic purposes.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18823795     DOI: 10.1016/j.jvir.2008.07.014

Source DB:  PubMed          Journal:  J Vasc Interv Radiol        ISSN: 1051-0443            Impact factor:   3.464


  18 in total

Review 1.  Transcatheter embolization therapy in liver cancer: an update of clinical evidences.

Authors:  Yì-Xiáng J Wáng; Thierry De Baere; Jean-Marc Idée; Sébastien Ballet
Journal:  Chin J Cancer Res       Date:  2015-04       Impact factor: 5.087

Review 2.  Advances in Biomaterials and Technologies for Vascular Embolization.

Authors:  Jingjie Hu; Hassan Albadawi; Brian W Chong; Amy R Deipolyi; Rahul A Sheth; Ali Khademhosseini; Rahmi Oklu
Journal:  Adv Mater       Date:  2019-06-06       Impact factor: 30.849

3.  In vivo evaluation of callispheres microspheres in the porcine renal artery embolization model.

Authors:  Baosheng Ren; Wansheng Wang; Jian Shen; Caifang Ni; Xiaoli Zhu
Journal:  Am J Transl Res       Date:  2019-07-15       Impact factor: 4.060

4.  Temperature-sensitive poly(N-isopropylacrylamide-co-butyl methylacrylate) nanogel as an embolic agent: distribution, durability of vascular occlusion, and inflammatory reactions in the renal artery of rabbits.

Authors:  H Zhao; C Zheng; G Feng; Y Zhao; H Liang; H Wu; G Zhou; B Liang; Y Wang; X Xia
Journal:  AJNR Am J Neuroradiol       Date:  2012-08-02       Impact factor: 3.825

Review 5.  Chemoembolization of hepatocellular carcinoma with HepaSphere™.

Authors:  Katerina Malagari; Anastasia Pomoni; Dimitrios Filippiadis; Dimitrios Kelekis
Journal:  Hepat Oncol       Date:  2015-05-05

6.  Calibrated Bioresorbable Microspheres as an Embolic Agent: An Experimental Study in a Rabbit Renal Model.

Authors:  Lihui Weng; Davis Seelig; Parinaz Rostamzadeh; Jafar Golzarian
Journal:  J Vasc Interv Radiol       Date:  2015-03-29       Impact factor: 3.464

7.  A novel, non-adhesive, precipitating liquid embolic implant with intrinsic radiopacity: feasibility and safety animal study.

Authors:  Zsolt Kulcsár; Agnieszka Karol; Peter W Kronen; Pfundstein Svende; Karina Klein; Olivier Jordan; Isabel Wanke
Journal:  Eur Radiol       Date:  2016-06-14       Impact factor: 5.315

8.  Treatment of angiomyolipoma at a tertiary care centre: the decision between surgery and angioembolization.

Authors:  Stephen Faddegon; Alan So
Journal:  Can Urol Assoc J       Date:  2011-03-01       Impact factor: 1.862

9.  Development of "imageable" beads for transcatheter embolotherapy.

Authors:  Karun V Sharma; Matthew R Dreher; Yiqing Tang; William Pritchard; Oscar A Chiesa; John Karanian; Jennifer Peregoy; Babak Orandi; David Woods; Danielle Donahue; Juan Esparza; Guy Jones; Sean L Willis; Andrew L Lewis; Bradford J Wood
Journal:  J Vasc Interv Radiol       Date:  2010-06       Impact factor: 3.464

Review 10.  Transarterial chemoembolization for hepatocellular carcinoma: A review of techniques.

Authors:  Norihiro Imai; Masatoshi Ishigami; Yoji Ishizu; Teiji Kuzuya; Takashi Honda; Kazuhiko Hayashi; Yoshiki Hirooka; Hidemi Goto
Journal:  World J Hepatol       Date:  2014-12-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.